HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease.

AbstractBACKGROUND:
The clinical course of Epstein-Barr virus (EBV)-associated smooth muscle tumors is variable and there are no reports in patients with mixed T-cell chimerism after bone marrow transplantation (BMT).
OBSERVATIONS:
A child with X-linked severe combined immunodeficiency disease developed multiple renal and pulmonary leiomyomata 8 years after haploidentical BMT. Epstein-Barr viral DNA was detectable in the blood and in situ hybridization for EBV-encoded RNAs was positive in the tumor. The tumors have been radiographically stable, chimerism remains mixed, and plasma EBV DNA has been repeatedly negative for over 2 years after donor lymphocyte infusion.
CONCLUSIONS:
EBV-associated smooth muscle tumors may occur in patients who are partially reconstituted after BMT for severe combined immunodeficiency and may not require surgery or chemotherapy.
AuthorsSrilatha Atluri, Kathleen Neville, Mary Davis, Kent A Robertson, Francis E Marshalleck, Dennis P O'Malley, Rebecca H Buckley, Robert P Nelson Jr
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 29 Issue 3 Pg. 166-72 (Mar 2007) ISSN: 1077-4114 [Print] United States
PMID17356396 (Publication Type: Case Reports, Journal Article)
Topics
  • Bone Marrow Transplantation (adverse effects, immunology)
  • Child
  • Chimerism
  • Epstein-Barr Virus Infections (complications, pathology)
  • Humans
  • Kidney Neoplasms (diagnosis, virology)
  • Leiomyomatosis (pathology, virology)
  • Lung Neoplasms (diagnosis, virology)
  • Male
  • Sensitivity and Specificity
  • Severe Combined Immunodeficiency (immunology, therapy, virology)
  • T-Lymphocytes (pathology, virology)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: